Moderate consumption of a polyphenolic-enriched wine attenuates alcohol-associated alterations in hepatic biomarkers in overweight subjects: a randomized clinical trial.
Inés Urquiaga, Gerard Casaubon, Druso Pérez et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the effects of a polyphenol-enriched red wine on hepatic biomarkers in overweight adults. Participants consumed either the polyphenol-enriched wine or a reduced-alcohol control wine for 5-6 weeks. The study found a significant reduction in serum alanine aminotransferase levels in the polyphenol group compared to the control, indicating potential protective effects against alcohol-related liver alterations.
Key findings
- GSPE wine consumption led to a significant reduction in serum alanine aminotransferase levels compared to baseline and control.
- Control wine resulted in a significant increase in plasma uric acid levels and total antioxidant activity.
- Control wine also caused a slight but significant decrease in albumin concentration.
Why it matters
Understanding the impact of polyphenol-enriched wines on liver health can inform dietary recommendations for overweight individuals, particularly those at risk for metabolic syndrome. This research highlights potential benefits of specific wine components in mitigating alcohol-related liver damage.